Total Payments
$2,757
2024 Payments
$759.94
Companies
19
Transactions
119
Medicare Patients
2,993
Medicare Billing
$151,063
Payment Breakdown by Category
Food & Beverage$2,757 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,757 | 119 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $489.43 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $394.77 | 21 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $309.31 | 5 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $277.46 | 14 | $0 (2024) |
| Amgen Inc. | $209.41 | 10 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $209.13 | 8 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $191.71 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $135.82 | 6 | $0 (2024) |
| Novo Nordisk Inc | $127.62 | 7 | $0 (2024) |
| Merck Sharp & Dohme LLC | $108.49 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $759.94 | 29 | Lilly USA, LLC ($365.15) |
| 2023 | $355.04 | 19 | E.R. Squibb & Sons, L.L.C. ($80.46) |
| 2022 | $648.05 | 31 | Novartis Pharmaceuticals Corporation ($173.89) |
| 2021 | $994.17 | 40 | Janssen Pharmaceuticals, Inc ($309.31) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $28.31 | General |
| Category: Cardiovascular | ||||||
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: DIABETES | ||||||
| 09/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Endocrinology | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $1.32 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Endocrinology | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: DIABETES | ||||||
| 08/07/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $23.01 | General |
| Category: Coronary | ||||||
| 08/01/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $30.03 | General |
| Category: Medical Device | ||||||
| 07/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: DIABETES | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/22/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.94 | General |
| Category: Cardiovascular | ||||||
| 05/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Diabetes | ||||||
| 05/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/02/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: Diabetes | ||||||
| 04/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: DIABETES | ||||||
| 02/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 679 | 876 | $250,662 | $35,567 |
| 2022 | 10 | 678 | 858 | $252,420 | $35,497 |
| 2021 | 12 | 774 | 1,010 | $282,950 | $40,983 |
| 2020 | 11 | 862 | 1,126 | $311,769 | $39,016 |
Total Patients
2,993
Total Services
3,870
Medicare Billing
$151,063
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 219 | $120,450 | $18,166 | 15.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 102 | 138 | $51,750 | $8,781 | 17.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 151 | 221 | $4,570 | $1,856 | 40.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 15 | 15 | $9,630 | $1,828 | 19.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 19 | 19 | $3,344 | $1,367 | 40.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $3,672 | $1,193 | 32.5% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 95 | 103 | $38,934 | $942.70 | 2.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 46 | 46 | $6,670 | $480.79 | 7.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 11 | 11 | $1,562 | $380.82 | 24.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 30 | $8,250 | $330.60 | 4.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 13 | 13 | $1,560 | $210.86 | 13.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 20 | 27 | $270.00 | $30.13 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 208 | $114,400 | $17,958 | 15.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 128 | $48,000 | $7,830 | 16.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 28 | 28 | $17,976 | $3,715 | 20.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 25 | 25 | $4,400 | $1,714 | 38.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 43 | 43 | $4,644 | $1,486 | 32.0% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2022 | 103 | 114 | $43,092 | $1,020 | 2.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 62 | 67 | $9,715 | $663.24 | 6.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 152 | 212 | $4,240 | $627.63 | 14.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 14 | 14 | $728.00 | $295.26 | 40.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 19 | $5,225 | $187.52 | 3.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 146 | 212 | $116,692 | $20,062 | 17.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 119 | 170 | $63,750 | $11,172 | 17.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 17 | 17 | $10,914 | $2,308 | 21.1% |
About Rina Basin
Rina Basin is a Family healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/01/2014. The National Provider Identifier (NPI) number assigned to this provider is 1881097152.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rina Basin has received a total of $2,757 in payments from pharmaceutical and medical device companies, with $759.94 received in 2024. These payments were reported across 119 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,757).
As a Medicare-enrolled provider, Basin has provided services to 2,993 Medicare beneficiaries, totaling 3,870 services with total Medicare billing of $151,063. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Brooklyn, NY
- Active Since 10/01/2014
- Last Updated 02/23/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1881097152
Products in Payments
- MOUNJARO (Drug) $315.66
- XARELTO (Drug) $309.31
- JARDIANCE (Drug) $287.01
- ENTRESTO (Drug) $266.57
- FARXIGA (Drug) $225.33
- Repatha (Biological) $209.41
- MULTAQ (Drug) $209.13
- LEQVIO (Drug) $128.20
- CAMZYOS (Drug) $108.77
- ELIQUIS (Drug) $82.94
- Rybelsus (Drug) $74.87
- VERQUVO (Drug) $66.71
- Ozempic (Drug) $52.75
- JANUVIA (Drug) $41.78
- Korlym (Drug) $39.54
- Vascepa (Drug) $35.39
- (CK4) MCOT (Device) $30.03
- VYNDAQEL (Drug) $29.67
- TRULANCE (Drug) $28.78
- VYNDAMAX (Drug) $23.35
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Brooklyn
Susan Weiss, Np, NP
Family — Payments: $20,923
Family $20,923
Ms. Abigail Hunter, Fnp, FNP
Family — Payments: $18,034
Family $18,034
Seida Velija
Family — Payments: $15,903
Family $15,903
Ami Lam
Family — Payments: $15,616
Family $15,616
Christina Lao
Family — Payments: $15,127
Family $15,127
Mrs. Kelly Morris, Fnp, FNP
Family — Payments: $8,415
Family $8,415